Skip to content

Psychometric Properties of Sit-to-stand Test in Spinal Cord Injury

Appropriate Methods and Psychometric Properties of Sit-to-stand Test in Ambulatory Patients With Spinal Cord Injury

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03625193
Enrollment
182
Registered
2018-08-10
Start date
2017-10-01
Completion date
2019-08-31
Last updated
2019-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Keywords

Sit-to-stand test, Psychometric properties

Brief summary

1. Do different arm placements (including arms on armrests/devices, arms on knees, arms free, and arm crossed over chest) influence outcomes of sit-to-stand test (STST) in ambulatory individuals with spinal cord injury (SCI)? 2. What are the factors associated with ability to perform STST in ambulatory individuals with SCI? 3. Are the single-time sit-to-stand test (STSST) and five-time sit-to-stand test (FTSST) reliable, valid and responsive to determine functional alteration in ambulatory individuals with SCI?

Detailed description

* To cross-sectionally compare characteristics (duration and amount of lower limb loading) of STS movements among 4 arm placement conditions (arms on armrests/devices, arms on knees, arms free, and arm crossed over chest) in ambulatory patients with SCI. * To investigate reliability (inter-rater, intra-rater, and test-retest), standard error of measurement and minimal detectable changes of the STSST and FTSST in ambulatory patients with SCI. * To investigate concurrent validity and factors associated with ability of the STSST and FTSST in ambulatory patients with SCI. * To investigate the ability of the STSST and FTSST to predict the risk of falls over 1, 3 and 6 months in ambulatory patients with SCI. * To investigate internal and external responsiveness of the STSST and FTSST to detect changes on walking ability over 1, 3 and 6 months in ambulatory patients with SCI. * To estimate the minimal clinically important difference or clinical significance of the FTSST in ambulatory patients with SCI.

Interventions

None listed

Sponsors

Khon Kaen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Body mass index (BMI) between 18.5 - 29.9 kg/m2 * Having an incomplete SCI from traumatic or non-traumatic causes * Ability of independent standing up from a chair with or without hand support * Ability of independent walking with or without walking device over at least 10 meters continuously. * Ability to follow commands used in the studies

Exclusion criteria

Any ambulatory individuals with incomplete SCI who present signs and symptoms that might affect ability to perform STST will be excluded from the study such as * Pain in the muscles or joints with an intensity of pain more than 5 out of 10 on a numeric rating scale (NRS) * Joint deformities that affect mobility * Other neurological disorders such as having brain lesions * Unstable medical conditions * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Ability to perform single and five times sit-to-stand test among 4 arm conditionsChange over 6 monthsAbility to execute a single time sit-to-stand and time used for five times sit-to-stand

Secondary

MeasureTime frameDescription
10-meter walk testChange over 6 monthsChange in walking speed during 6-month follow-up
Fall eventsOver 6 monthsIncidence of fall during 6-month follow-up
Global rating of change score (GRC score)Change over 6 monthsLevel of change in subjects' independence in activities of daily life. The GRC score is divided into 15-point scale from -7 (a very great deal worse) to 0 (about the same/ not change) to 7 (a very great deal better).

Countries

Thailand

Contacts

Primary ContactLalita Khuna, PhD student
lalitakhuna@gmail.com+66637391999

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026